NASDAQ:CNCR   Loncar Cancer Immunotherapy ETF
Possible upward channelling stock. Will have to see if it bounces on support.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.